Chimaera Capital Limited v Pharmaust Limited [2007] FCA 1539

Chimaera Capital Limited v Pharmaust Limited [2007] FCA 1539

Chimaera failed to establish a seriously arguable case that Pharmaust's directors acted for an improper purpose or beyond power in proceeding with the rights issue prior to the EGM. The evidence did not support the inference that the rights issue was intended to change the shareholder majority to protect directors' positions, and the dire financial circumstances required management action. The balance of convenience did not favour granting interlocutory injunctive relief as the case against the directors was weak and there was risk of prejudice to the company and third parties if the rights issue was delayed.

Parties
Applicant: Chimaera Capital Limited; First Respondent: Pharmaust Limited; Second Respondent: Bryant McLarty; Third Respondent: Simon Owen; Fourth Respondent: Henry Gulev
Jurisdiction
Australia
Judgment Date
09 October 2007
Procedural Posture
Corporations – Interlocutory Motion / Ruling on Interlocutory Injunctive Relief
Outcome
Interlocutory injunction dismissed
Legal Topics
Directors' Duties, Oppression Remedy, Improper Purpose, Interlocutory Injunctions, Shareholder Rights, Corporate Governance
Corporations Law Equity Directors' Duties Oppression Remedy Improper Purpose Interlocutory Injunctions Shareholder Rights Corporate Governance

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 14 Party arguments 2 Amounts and remedies 11
Sign in to unlock

Parties

Chimaera Capital Limited

Applicant

Pharmaust Limited

First Respondent

Bryant McLarty

Second Respondent

Simon Owen

Third Respondent

Henry Gulev

Fourth Respondent

Procedural Posture

Corporations – Interlocutory Motion / Ruling on Interlocutory Injunctive Relief

Legal Issues

  1. 1 Whether directors acted for improper purpose in conducting a rights issue prior to a requisitioned EGM for their removal
  2. 2 Whether a 'caretaker director' doctrine restricts directors' powers in these circumstances
  3. 3 Whether the conduct of the directors was oppressive or unfairly prejudicial under s 232 of the Corporations Act 2001 (Cth)

Ratio Decidendi

Chimaera failed to establish a seriously arguable case that Pharmaust's directors acted for an improper purpose or beyond power in proceeding with the rights issue prior to the EGM. The evidence did not support the inference that the rights issue was intended to change the shareholder majority to protect directors' positions, and the dire financial circumstances required management action. The balance of convenience did not favour granting interlocutory injunctive relief as the case against the directors was weak and there was risk of prejudice to the company and third parties if the rights issue was delayed.

Court Disposition

Interlocutory injunction dismissed

Orders

  • The claim for interlocutory relief is dismissed.
  • The costs of the application for interlocutory relief are reserved.